Recent clinical trials have shown that combination therapy with pegylated interferon and ribavirin can achieve a sustained virological response in the majority of patients with chronic hepatitis C who qualify for treatment. However, because many patients are unable to be treated (or choose not to due to ...
Several factors are involved in the selective activation of T helper 1 or T helper 2 cells, such as the type of antigen-presenting cells involved in the immune response and the different physical characteristics of antigens. The aim of this work was to evaluate if adding other antigens to tetanus toxoid ...